Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic

Bibliographic Details
Main Authors: Naviglio S, Pagnini I, DeLibero C, Caputo R, Cattalini M, Taddio A, Simonini G, Lepore L, Cimaz R
Format: Article
Language:English
Published: BMC 2011-09-01
Series:Pediatric Rheumatology Online Journal
id doaj-bd7d4e5386f74df9ace74514fa368c51
record_format Article
spelling doaj-bd7d4e5386f74df9ace74514fa368c512020-11-24T21:41:04ZengBMCPediatric Rheumatology Online Journal1546-00962011-09-019Suppl 1P22010.1186/1546-0096-9-S1-P220Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologicNaviglio SPagnini IDeLibero CCaputo RCattalini MTaddio ASimonini GLepore LCimaz R
collection DOAJ
language English
format Article
sources DOAJ
author Naviglio S
Pagnini I
DeLibero C
Caputo R
Cattalini M
Taddio A
Simonini G
Lepore L
Cimaz R
spellingShingle Naviglio S
Pagnini I
DeLibero C
Caputo R
Cattalini M
Taddio A
Simonini G
Lepore L
Cimaz R
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
Pediatric Rheumatology Online Journal
author_facet Naviglio S
Pagnini I
DeLibero C
Caputo R
Cattalini M
Taddio A
Simonini G
Lepore L
Cimaz R
author_sort Naviglio S
title Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
title_short Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
title_full Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
title_fullStr Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
title_full_unstemmed Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
title_sort superior efficacy of adalimumab in treating childhood refractory chronic uveitis when used as first biologic
publisher BMC
series Pediatric Rheumatology Online Journal
issn 1546-0096
publishDate 2011-09-01
work_keys_str_mv AT naviglios superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic
AT pagninii superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic
AT deliberoc superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic
AT caputor superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic
AT cattalinim superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic
AT taddioa superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic
AT simoninig superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic
AT leporel superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic
AT cimazr superiorefficacyofadalimumabintreatingchildhoodrefractorychronicuveitiswhenusedasfirstbiologic
_version_ 1725923397379031040

Similar Items